Copy number architectures define treatment-mediated selection of lethal prostate cancer clones. (2023)

First Author: Hasan A

Attributed to: Leveraging circulating tumour DNA (ctDNA) to dissect the evolutionary genomic dynamics of drug resistance in prostate cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.25418/crick.23952636

Publication URI: https://crick.figshare.com/articles/journal_contribution/Copy_number_architectures_define_treatment-mediated_selection_of_lethal_prostate_cancer_clones_/23952636

Type: Other